Pancreatic cancer begins when abnormal cells in the pancreas grow and divide out of control and form a tumor. The pancreas is a gland located deep in the abdomen, between the stomach and the spine. It makes enzymes that help digestion and hormones that control blood-sugar levels.
According to the American Cancer Society, the five-year survival rate of pancreatic cancer is 9 percent. Pancreatic cancer is diagnosed in men more often than women. Risk factors for pancreatic cancer include smoking, diabetes, chronic inflammation of the pancreas, obesity, and older age. Most people diagnosed with pancreatic cancer are 65 years or older.
The signs and symptoms of pancreatic cancer can be weight loss, upper abdominal pain, jaundice and more. There are multiple options for treatment of pancreatic cancer including chemotherapy, radiation therapy, surgery, palliative care and clinical trial options.
Pancreatic cancer can be difficult to diagnose early because signs and symptoms don’t occur in the early stages of the disease. Additionally, the signs and symptoms of the disease are often mistaken for other illnesses.
There are a few factors that affect the prognosis of pancreatic cancer, and they vary with each individual’s cancer case. When looking at treatment options, it is important to look at the stage of the cancer, if the tumor is removable, the patient’s general health and health history, and if the cancer is new or recurring.
Regardless of the stage of your pancreatic cancer, or your individual case, Massive Bio is able to help you simplify the process of getting access to active and effective clinical trials.